Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Necrosis01:16

Necrosis

4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cell size modulates ferroptosis susceptibility.

eLife·2026
Same author

Discovery of a paralog-selective p300 protein degrader with potent anti-cancer activity in hematological malignancies.

Nature communications·2026
Same author

Dissecting Complex Interactions Between Ferroptosis and the Proteasome.

bioRxiv : the preprint server for biology·2026
Same author

Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-Up.

American journal of hematology·2026
Same author

Cell size modulates ferroptosis susceptibility.

bioRxiv : the preprint server for biology·2025
Same author

A guide to using small-molecule ferroptosis inhibitors.

Nature structural & molecular biology·2025

相关实验视频

Updated: Sep 8, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.2K

脂质组成改变了铁的敏感性

Vivian S Park1, Lauren E Pope2, Justin P Ingram3

  • 1AbbVie (United States), North Chicago, United States.

Cancer research
|September 5, 2025
PubMed
概括

癌细胞在3D培养和瘤中抵抗细胞死亡过程. 这些情况的脂质变化降低了对GPX4抑制剂的敏感性,影响了药物开发.

更多相关视频

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

1.0K
Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

458

相关实验视频

Last Updated: Sep 8, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.2K
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

1.0K
Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

458

科学领域:

  • 细胞生物学
  • 生物化学
  • 癌症学

背景情况:

  • 铁死是一种依赖于铁的细胞死亡,以脂质过氧化为标志.
  • 通过降低脂质过氧化物来抑制铁.
  • GPX4是潜在的药物标,需要了解抑制剂的敏感性.

研究的目的:

  • 研究影响癌症GPX4抑制剂敏感性的因素.
  • 确定3D培养和体内条件对耐铁的影响.
  • 确定铁变异敏感性的机制.

主要方法:

  • 在2D和3D癌细胞培养中通过GPX4降低诱导铁.
  • 在二维培养,三维球体和老鼠异种移植中评估GPX4抑制剂的疗效.
  • 分析了脂质变化,特别是单不和脂肪酸 (MUFA) 和多不和脂肪酸 (PUFA),使用stearoyl-CoA脱酶 (SCD) 的基因表达.

主要成果:

  • 在2D培养物中减少GPX4表达诱导铁,但在小鼠异种移植中不一致.
  • 与二维相比,3D球形培养物对GPX4抑制具有抗性.
  • 3D生长和体内瘤显示MUFA-PLs增加和PUFA-PLs降低,与SCD上调相关,促进铁死耐药性.

结论:

  • 癌细胞适应3D和体内环境,包括脂质组重塑,使其对GPX4抑制剂产生抗性.
  • 改变的MUFA/PUFA比率是限制GPX4抑制剂有效性的关键机制.
  • 研究结果表明,有办法克服对诱导铁死药物的耐药性.